GENTEX CORP
Business
GENTEX CORP designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection technologies. Its principal products include interior and exterior electrochromic automatic-dimming and non-dimming rearview mirrors and associated automotive electronics, dimmable aircraft windows, commercial smoke and signaling devices, HomeLink and connected-vehicle systems, biometrics and sensor technologies, nanofiber chemical sensing, medical lighting, and smart-home PLACE safety products. The company operates key business segments in automotive rearview mirrors and electronics, dimmable aircraft windows, fire protection, and emerging nanofiber, medical, and biometric technologies. It sells globally to automotive OEMs, suppliers, aftermarket customers, airlines, distributors, retailers, and direct customers across North America, Europe, and Asia, supported by worldwide sales, engineering, and distribution locations.
Summary from filing dated 2025-02-25
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| NET SALES | 2,534 | 2,313 | 2,299 | 1,919 | 1,731 | |
| COST OF GOODS SOLD | 1,668 | 1,542 | 1,537 | 1,309 | 1,111 | |
| Gross profit | 867 | 771 | 763 | 610 | 620 | |
| Engineering, research and development | 203 | 181 | 154 | 133 | 118 | |
| Selling, general and administrative | 178 | 121 | 113 | 106 | 92 | |
| Severance expense | 12 | 0 | 0 | — | — | |
| Impairment Charges | 0 | 9 | 0 | 0 | — | |
| Total operating expenses | 393 | 311 | 267 | 240 | 210 | |
| Income from operations | 474 | 460 | 496 | 370 | 410 | |
| Investment (loss) income, net | −1 | 13 | 13 | — | — | |
| Other, net | −12 | −915,731 | −4 | −5 | 3 | |
| Total other (loss) income | −13 | 12 | 9 | −283,050 | 7 | |
| Income before provision for income taxes | 461 | 472 | 505 | 370 | 416 | |
| PROVISION FOR INCOME TAXES | 76 | 68 | 77 | 51 | 56 | |
| NET INCOME | 385 | 404 | 428 | 319 | — | |
| Less: Net loss attributable to non-controlling interests | −159,290 | 0 | 0 | — | — | |
| NET INCOME ATTRIBUTABLE TO GENTEX CORPORATION | 385 | 404 | 428 | 319 | 361 | |
| Basic (in dollars per share) | 1.74 | 1.77 | 1.84 | 1.36 | 1.51 | |
| Diluted (in dollars per share) | 1.74 | 1.76 | 1.84 | 1.36 | 1.5 | |
| Cash Dividends Declared per Share (in dollars per share) | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2022 2022-05-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 146 | 233 | 226 | 215 | — | |
| Short-term investments | 5 | 22 | 14 | 23 | — | |
| Accounts receivable, net | 369 | 295 | 322 | 276 | — | |
| Inventories, net | 516 | 436 | 402 | 404 | — | |
| Prepaid expenses and other | 93 | 50 | 33 | 26 | — | |
| Total current assets | 1,128 | 1,037 | 998 | 949 | — | |
| Land, buildings and improvements | 591 | 531 | 472 | 377 | — | |
| Machinery and equipment | 1,240 | 1,065 | 1,012 | 936 | — | |
| Construction-in-process | 83 | 178 | 158 | 166 | — | |
| Total Plant and Equipment | 1,915 | 1,774 | 1,642 | 1,478 | — | |
| Less- Accumulated depreciation | −1,124 | −1,046 | −989 | −928 | — | |
| Net Plant and Equipment | 791 | 728 | 653 | 550 | — | |
| Goodwill | 357 | 341 | 340 | 314 | — | |
| Long-term investments | 273 | 340 | 299 | 202 | — | |
| Intangible assets, net | 189 | 195 | 214 | 219 | — | |
| Deferred tax asset | 108 | 53 | 41 | 26 | — | |
| Patents and other assets, net | 81 | 66 | 67 | 68 | — | |
| Total Other Assets | 1,009 | 995 | 961 | 829 | — | |
| TOTAL ASSETS | 2,929 | 2,761 | 2,611 | 2,327 | — | |
| Accounts payable | 249 | 168 | 184 | 152 | — | |
| Salaries, wages and vacation | 23 | 20 | 23 | 18 | — | |
| Income taxes | 846,965 | 439,545 | 693,391 | 19 | — | |
| Royalties | 29 | 21 | 21 | 19 | — | |
| Dividends payable | 26 | 27 | 28 | 28 | — | |
| Short-term debt | 4 | 0 | — | — | — | |
| Other | 56 | 16 | 15 | 15 | — | |
| Total current liabilities | 388 | 253 | 272 | 251 | — | |
| OTHER NON-CURRENT LIABILITIES | 49 | 36 | 27 | 11 | — | |
| DEFERRED INCOME TAXES | 908,922 | 0 | — | — | — | |
| TOTAL LIABILITIES | 438 | 289 | 299 | 261 | — | |
| REDEEMABLE NON-CONTROLLING INTEREST | 3 | 0 | — | — | — | |
| Common stock, par value 0.06 per share; 400,000,000 shares authorized; 215,445,024 and 227,207,472 shares issued and outstanding in 2025 and 2024, respectively. | 13 | 14 | 14 | 14 | 5 | |
| Additional paid-in capital | 1,009 | 1,010 | 968 | 917 | — | |
| Retained earnings | 1,466 | 1,450 | 1,337 | 1,148 | — | |
| Unrealized income (loss) on investments, net | 1 | −591,605 | −2 | −10 | — | |
| Unrealized loss on derivatives | −768,985 | 0 | — | — | — | |
| Cumulative translation adjustment | −310,305 | −6 | −5 | −4 | — | |
| TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT | 2,488 | 2,468 | 2,313 | 2,066 | — | |
| Non-controlling Interest | 0 | 4 | 0 | — | — | |
| TOTAL SHAREHOLDERS' INVESTMENT | 2,488 | 2,472 | 2,313 | 2,066 | — | |
| TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT | 2,929 | 2,761 | 2,611 | 2,327 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 104 | 95 | 93 | 97 | 99 | |
| Gain on disposal of assets | −3 | −1 | −355,544 | −70,736 | −488,750 | |
| Loss on disposal of assets | 25,763 | 90,145 | 443,373 | 28,424 | 230,933 | |
| Gain on sale of investments and equity method investment income | −3 | −5 | −5 | −392,040 | −1 | |
| Loss on sale of investments and equity method investment losses | 8 | 10 | 11 | 2 | 307,490 | |
| Provision for credit losses | 7 | 0 | 0 | — | — | |
| Remeasurement of earnout provision | 3 | 0 | 0 | — | — | |
| Deferred income taxes | −18 | −12 | −18 | −18 | −42 | |
| Stock based compensation expense related to employee stock options, employee stock purchases and restricted stock | 37 | 40 | 39 | 30 | 27 | |
| Impairment charges - investments | 14 | 0 | 0 | — | — | |
| Impairment charges - goodwill and intangible assets | 0 | 9 | 0 | — | — | |
| Accounts receivable | −15 | 27 | −45 | −27 | 35 | |
| Inventories | 18 | −33 | 2 | −88 | −90 | |
| Prepaid expenses and other | 214,617 | −10 | −4 | −29 | −20 | |
| Accounts payable | 52 | −26 | 41 | 37 | 7 | |
| Accrued liabilities | −2 | 1 | −6 | 15 | −14 | |
| Net cash flows provided by operating activities | 587 | 498 | 537 | 338 | 362 | |
| Sales proceeds | 74 | 43 | 59 | 37 | 56 | |
| Maturities and calls | 3 | 16 | 17 | 4 | 28 | |
| Purchases | −26 | −51 | −81 | −18 | −100 | |
| VOXX share purchases | 0 | −31 | −17 | −383,843 | — | |
| Purchase of technology investments | −23 | −28 | −71 | −46 | — | |
| Plant and equipment additions | −129 | −145 | −184 | −146 | −69 | |
| Proceeds from sale of plant and equipment | 8 | 3 | 292,723 | 313,917 | 3 | |
| Acquisition of businesses, net of cash acquired | −156 | −3 | −19 | 0 | −12 | |
| Loans to technology investment partners | −16 | 0 | 0 | — | — | |
| Increase in other assets | −2 | −7 | −4 | −4 | −6 | |
| Net cash used for investing activities | −267 | −202 | −299 | −173 | −113 | |
| Issuance of common stock from stock plan transactions | 14 | 27 | 29 | 17 | 30 | |
| Cash dividends paid | −107 | −110 | −112 | −113 | −115 | |
| Repurchases of common stock | −315 | −206 | −147 | −113 | −325 | |
| Net cash used for financing activities | −408 | −289 | −230 | −209 | −410 | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | −88 | 7 | 8 | −44 | −161 | |
| Change in Property and equipment in accounts payable and accrued expenses and other current liabilities | 17 | −10 | 7 | 15 | — |